Research & development

Since first establishing its pharmaceutical division in 1947, with the construction of its factory in Kita-ku, Nagoya, Kowa has gone on to establish a global presence in the pharmaceutical industry with offices located in the United States, Europe and Asia.

With a commitment to groundbreaking research, clinical development and marketing, Kowa continue to bring quality products to the global market.

For more information on our research and development program, facilities, and our affiliates worldwide please visit https://www.kowa.co.jp/eng/business/health/index.html

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Find out more

You are now leaving the kowapharmaceuticals.eu website.

This link will take you to a third party website to which our Privacy policy does not apply. You are solely responsible for your interactions with any third party website. We encourage you to read the privacy policy of every website you visit.

CONTINUE TO THIRD PARTY WEBSITE

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us






    I confirm I have read and accept the terms of the Privacy policy